| Literature DB >> 23744781 |
Benjamin D Hopkins1, Barry Fine, Nicole Steinbach, Meaghan Dendy, Zachary Rapp, Jacquelyn Shaw, Kyrie Pappas, Jennifer S Yu, Cindy Hodakoski, Sarah Mense, Joshua Klein, Sarah Pegno, Maria-Luisa Sulis, Hannah Goldstein, Benjamin Amendolara, Liang Lei, Matthew Maurer, Jeffrey Bruce, Peter Canoll, Hanina Hibshoosh, Ramon Parsons.
Abstract
Phosphatase and tensin homolog on chromosome ten (PTEN) is a tumor suppressor and an antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576-amino acid translational variant of PTEN, termed PTEN-Long, that arises from an alternative translation start site 519 base pairs upstream of the ATG initiation sequence, adding 173 N-terminal amino acids to the normal PTEN open reading frame. PTEN-Long is a membrane-permeable lipid phosphatase that is secreted from cells and can enter other cells. As an exogenous agent, PTEN-Long antagonized PI3K signaling and induced tumor cell death in vitro and in vivo. By providing a means to restore a functional tumor-suppressor protein to tumor cells, PTEN-Long may have therapeutic uses.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23744781 PMCID: PMC3935617 DOI: 10.1126/science.1234907
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728